Clinical Research Nursing Scopes and Standards Open for Comment
Document Open for Comment
The International Association of Clinical Research Nurses (IACRN) is seeking professional and public input on the first scope and standards of practice for the specialty practice of Clinical Research Nursing. The document, Scope and Standards of Practice for Clinical Research Nursing, was formally presented at the 7th annual IACRN conference, in Baltimore, MD on October 15, 2015. The document is currently open for public comments at http://iacrn.memberlodge.org/
The newly released draft document establishes formal direction for the clinical research nurse around the following definition: Clinical Research Nursing is the specialized practice of professional nursing focused on maintaining equilibrium between care of the research participant and fidelity to the research protocol. This specialty practice incorporates human subject protection; care coordination and continuity; contribution to clinical science; clinical practice; and study management throughout a variety of professional roles, practice settings, and clinical specialties.
IACRN has clinical research nurse representation from 34 states, as well as in Great Britain, Australia, Canada, China, Ireland, Israel, Japan, Spain, Switzerland, and Taiwan. For more information, see the IACRN website listed above.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
